Lab Test

JAK2 Exon 12 Mutation Detection

JAK2 Exon 12 Non-V617F Mutation Detection, erythrocytosis, Polycythemia Vera

Test Codes

EPIC: LAB6911, Beaker: GJ12G

Department

Molecular Pathology

Specimen Collection Criteria

Collect: Blood OR Bone Marrow.

  • Blood: 10.0 mL whole blood in Lavender-top EDTA tubes or Yellow-top ACD tubes. (Minimum: 5.0 mL)
  • Bone Marrow: 1.0 mL bone marrow aspirate in a Lavender-top EDTA tube. (Minimum: 0.5 mL)

Physician Office/Draw Specimen Preparation

Do not freeze specimens. Maintain specimens refrigerated (preferred) (2-8°C or 36-46°F) or at room temperature (20-26°C or 68-78.8°F) prior to transport.

Preparation for Courier Transport

Transport: 10.0 mL whole blood or 1.0 mL bone marrow, at room temperature (20-26°C or 68-78.8°F) or refrigerated (preferred) (2-8°C or 36-46°F). (Minimum: 5.0 mL whole blood or 0.5 mL bone marrow)

Rejection Criteria

  • Frozen specimens.
  • Centrifuged specimens.
  • Mislabeled or unlabeled tubes.
  • Specimens collected in heparin tubes (Green-top), clot tubes (Red-top), or SST tubes.
  • Specimens not collected and processed as indicated.

Clients will be notified of any cancellation of testing.

In-Lab Processing

Do not freeze specimens. Maintain specimen refrigerated (2-8°C or 36-46°F) prior to testing. 

Storage

Specimen Stability for Testing:

Room temperature (20-26°C or 68-78.8°F): 72 hours
Refrigerated (2-8°C or 36-46°F): 7 days
Frozen (-20°C/-4°F or below): Unacceptable

Specimen Storage in Department Prior to Disposal:

Refrigerated (2-8°C or 36-46°F): 7 days

Extracted DNA may be available for additional testing if clinically indicated. Contact the Molecular Pathology Laboratory for verification.

Laboratory

Royal Oak Molecular Pathology Laboratory

Performed

Once per week.
Results available in 7-10 days. 

Reference Range

Negative (no mutation).

Test Methodology

Polymerase chain reaction (PCR) amplification of exon 12 of the JAK2 gene with analysis of the products by capillary electrophoresis.

Interpretation

Somatic mutations in Exon 12 of the JAK2 gene are seen in Polycythemia Vera patients found to be negative for the JAK2 V617F mutation. The test is part of the WHO diagnostic algorithm for suspected Polycythemia Vera that is V617F negative. The Exon 12 mutation prevalence is less than 5% in Polycythemia Vera cases. Exon 12 Mutation Analysis is also useful in the workup of patients with erythrocytosis.

CPT Codes

81403

Contacts

Last Updated

10/30/2023

Microtainer® and Vacutainer® are registered trademarks of Becton, Dickinson and Company.
UroVysion® is a registered trademark of Abbott Laboratories. ThinPrep® is a registered trademark of Hologic, Incorporated.